Because of its pivotal role in the regulation of tumour-induced angiogenesis, cell cycle progression, tumour cell proliferation, survival, and tumour invasiveness, PKCβ is recognised as an important target for cancer treatment (Goekjian and Jirousek, 2001; Liu et al, 2004). Here, PRKCB is linked to neoplasm.